Catalyst for hydrogenation treatment and method for hydrogenation treatment of hydrocarbon oil
    3.
    发明授权
    Catalyst for hydrogenation treatment and method for hydrogenation treatment of hydrocarbon oil 失效
    用于氢化处理的催化剂和烃油的氢化处理方法

    公开(公告)号:US06306289B1

    公开(公告)日:2001-10-23

    申请号:US09423833

    申请日:1999-11-16

    IPC分类号: C10G4500

    摘要: A hydrotreating catalyst having both a high desulfurization activity and a denitrogenation activity and a method of hydrotreating a hydrocarbon oil using the same is provided. A hydrotreatment catalyst comprising a silica-alumina carrier loaded with at least one hydrogenation-active component; wherein (1) the silica content is in the range of 2 to 40% by weight based on the total weight of the carrier; and (2) in the spectrum obtained by nuclear magnetic resonance analysis (29Si-NMR), (i) the area of the peak at −80 ppm is 10% or more of the combined area of all the peaks; and (ii) the combined area of peaks at −80 ppm, −86 ppm and −92 ppm is 20% or more of the combined area of all peaks; a hydrotreating catalyst comprising a silica-alumina carrier containing a specific amount of a third component loaded with at lest one hydrogenation-active metal component and having a specific pore structure; and a method of hydrotreating a hydrocarbon oil comprising contacting a hydrocarbon oil with hydrogen in the presence of said hydrotreating catalyst.

    摘要翻译: 提供具有高脱硫活性和脱氮活性的加氢处理催化剂,以及使用其加氢处理烃油的方法。一种加氢处理催化剂,其包含负载有至少一种氢化活性组分的二氧化硅 - 氧化铝载体; 其中(1)基于所述载体的总重量,二氧化硅含量在2-40重量%的范围内; 和(2)在通过核磁共振分析(29Si-NMR)获得的光谱中,(i)-80ppm处的峰面积为所有峰的组合面积的10%以上; 和(ii)-80ppm,-86ppm和-92ppm的峰的组合面积为所有峰的组合面积的20%或更多; 加氢处理催化剂,其包含含有特定量的第三组分的二氧化硅 - 氧化铝载体,所述第三组分装载有至少一种氢化活性金属组分并具有特定孔结构; 以及加氢处理烃油的方法,包括在所述加氢处理催化剂存在下使烃油与氢气接触。

    Toll-like receptor 5 ligands and methods of use
    4.
    发明授权
    Toll-like receptor 5 ligands and methods of use 有权
    Toll样受体5配体及使用方法

    公开(公告)号:US08703146B2

    公开(公告)日:2014-04-22

    申请号:US10991347

    申请日:2004-11-16

    IPC分类号: A61K39/112

    摘要: The invention provides an immunomodulatory flagellin peptide having substantially the same amino acid sequence GALNEINNNLQRVRELAVQSANSTNSQSDLDSIQAEITQ (SEQ ID NO:44), or a modification thereof, and having toll like receptor 5 (TLR5) binding. The immunomodulatory flagellin peptide also can have substantially the same amino acid sequence TQFSGVKVLAQDNTLTIQVGANDGETIDIDLKQINS QTLGLDTL (SEQ ID NO:45); EGALNEINNNLQRVRELAVQSANSTNSQSDLDSIQAEITQRLNEIDRVNG (SEQ ID NO:46) or MAQVINTNSLSLLTQNNLNKSQSALGTAIERLSSGLRINSAKDDAAGQAIANF TANIKGLTQASRNANDGISIAQTTEGALNEINNNLQRVRELAVQS (SEQ ID NO:47), or a modification thereof. Also provided is an immunomodulatory flagellin peptide having substantially the same amino acid sequence LQKIDAALAQVDTLRSDLGAVQNRFNSAITNL (SEQ ID NO:48), or a modification thereof, and having toll like receptor 5 (TLR5) binding. The immunomodulatory flagellin peptide also can have substantially the same amino acid sequence TLRSDLGAVQNRFNSAITNLGNTVNNLSS (SEQ ID NO:49) or EQAAKTTENPLQKIDAALAQVDTLRSDLGAVQNRFNSAITNLGNTVNNLSS (SEQ ID NO:50), or a modification thereof. Further provided is an immunomodulatory flagellin peptide having substantially the same amino acid sequence GALNEINNNLQRVRELAVQSANSTNSQSDLDSIQAE ITQ (SEQ ID NO:44) and substantially the same amino acid sequence LQKIDAALAQVDTLRSDLGAVQNRFNSAITNL (SEQ ID NO:48), or a modification thereof, and having toll like receptor 5 (TLR5) binding. Methods of using immunomodulatory flagellin peptides additionally are provided.

    摘要翻译: 本发明提供具有基本上相同的氨基酸序列GALNEINNNLQRVRELAVQSANSTNSQSDLDSIQAEITQ(SEQ ID NO:44)或其修饰,并具有与受体5(TLR5)结合的通路的免疫调节鞭毛蛋白肽。 免疫调节鞭毛蛋白肽也可以具有基本相同的氨基酸序列TQFSGVKVLAQDNTLTIQVGANDGETIDIDLKQINS QTLGLDTL(SEQ ID NO:45); 或其修饰物。(SEQ ID NO:46)或MAQVINTNSLSLLTQNNLNKSQSALGTAIERLSSGLRINSAKDDAAGQAIANF TANIKGLTQASRNANDGISIAQTTEGALNEINNNLQRVRELAVQS(SEQ ID NO:47)或其修饰。 还提供了具有基本上相同的氨基酸序列LQKIDAALAQVDTLRSDLGAVQNRFNSAITNL(SEQ ID NO:48)或其修饰,并具有与受体5(TLR5)结合的通路的免疫调节鞭毛蛋白肽。 免疫调节鞭毛蛋白肽也可以具有基本上相同的氨基酸序列TLRSDLGAVQNRFNSAITNLGNTVNNLSS(SEQ ID NO:49)或EQAAKTTENPLQKIDAALAQVDTLRSDLGAVQNRFNSAITNLGNTVNNLSS(SEQ ID NO:50)或其修饰。 还提供了具有基本上相同的氨基酸序列GALNEINNNLQRVRELAVQSANSTNSQSDLDSIQAE ITQ(SEQ ID NO:44)和基本上相同的氨基酸序列LQKIDAALAQVDTLRSDLGAVQNRFNSAITNL(SEQ ID NO:48)或其修饰,并具有类似受体5的氨基酸序列的免疫调节鞭毛蛋白肽 (TLR5)结合。 另外提供了使用免疫调节鞭毛蛋白肽的方法。

    Toll-like receptor 5 ligands and methods of use
    9.
    发明申请
    Toll-like receptor 5 ligands and methods of use 有权
    Toll样受体5配体及使用方法

    公开(公告)号:US20050147627A1

    公开(公告)日:2005-07-07

    申请号:US10991347

    申请日:2004-11-16

    摘要: The invention provides an immunomodulatory flagellin peptide having substantially the same amino acid sequence GALNEINNNLQRVRELAVQSANSTNSQSDLDSIQAEITQ (SEQ ID NO:44), or a modification thereof, and having toll like receptor 5 (TLR5) binding. The immunomodulatory flagellin peptide also can have substantially the same amino acid sequence TQFSGVKVLAQDNTLTIQVGANDGETIDIDLKQINS QTLGLDTL (SEQ ID NO:45); EGALNEINNNLQRVRELAVQSANSTNSQSDLDSIQAEITQRLNEIDRVNG (SEQ ID NO:46) or MAQVINTNSLSLLTQNNLNKSQSALGTAIERLSSGLRINSAKDDAAGQAIANF TANIKGLTQASRNANDGISIAQTTEGALNEINNNLQRVRELAVQS (SEQ ID NO:47), or a modification thereof. Also provided is an immunomodulatory flagellin peptide having substantially the same amino acid sequence LQKIDAALAQVDTLRSDLGAVQNRFNSAITNL (SEQ ID NO:48), or a modification thereof, and having toll like receptor 5 (TLR5) binding. The immunomodulatory flagellin peptide also can have substantially the same amino acid sequence TLRSDLGAVQNRFNSAITNLGNTVNNLSS (SEQ ID NO:49) or EQAAKTTENPLQKIDAALAQVDTLRSDLGAVQNRFNSAITNLGNTVNNLSS (SEQ ID NO:50), or a modification thereof. Further provided is an immunomodulatory flagellin peptide having substantially the same amino acid sequence GALNEINNNLQRVRELAVQSANSTNSQSDLDSIQAE ITQ (SEQ ID NO:44) and substantially the same amino acid sequence LQKIDAALAQVDTLRSDLGAVQNRFNSAITNL (SEQ ID NO:48), or a modification thereof, and having toll like receptor 5 (TLR5) binding. Methods of using immunomodulatory flagellin peptides additionally are provided.

    摘要翻译: 本发明提供具有基本上相同的氨基酸序列GALNEINNNLQRVRELAVQSANSTNSQSDLDSIQAEITQ(SEQ ID NO:44)或其修饰,并具有与受体5(TLR5)结合的通路的免疫调节性鞭毛蛋白肽。 免疫调节鞭毛蛋白肽也可以具有基本相同的氨基酸序列TQFSGVKVLAQDNTLTIQVGANDGETIDIDLKQINS QTLGLDTL(SEQ ID NO:45); 或其修饰物。(SEQ ID NO:46)或MAQVINTNSLSLLTQNNLNKSQSALGTAIERLSSGLRINSAKDDAAGQAIANF TANIKGLTQASRNANDGISIAQTTEGALNEINNNLQRVRELAVQS(SEQ ID NO:47)或其修饰。 还提供了具有基本上相同的氨基酸序列LQKIDAALAQVDTLRSDLGAVQNRFNSAITNL(SEQ ID NO:48)或其修饰,并具有与受体5(TLR5)结合的通路的免疫调节鞭毛蛋白肽。 免疫调节鞭毛蛋白肽也可以具有基本上相同的氨基酸序列TLRSDLGAVQNRFNSAITNLGNTVNNLSS(SEQ ID NO:49)或EQAAKTTENPLQKIDAALAQVDTLRSDLGAVQNRFNSAITNLGNTVNNLSS(SEQ ID NO:50)或其修饰。 还提供了具有基本上相同的氨基酸序列GALNEINNNLQRVRELAVQSANSTNSQSDLDSIQAE ITQ(SEQ ID NO:44)和基本上相同的氨基酸序列LQKIDAALAQVDTLRSDLGAVQNRFNSAITNL(SEQ ID NO:48)或其修饰,并具有类似受体5的氨基酸序列的免疫调节鞭毛蛋白肽 (TLR5)结合。 另外提供了使用免疫调节鞭毛蛋白肽的方法。